Jacob Jay Gottlieb

Sanford C. Bernstein Asset Management is an investment advisor located in New York City. The firm is a subsidiary of AllianceBernstein LP and their ultimate parent is AXA SA (NYSE: AXA). They manage portfolios for individuals, trusts, pensions, endowments and foundations.

Founded in 1998 by Dr. Stuart T. Weisbrod, New York City-based Merlin BioMed Group LLC manages a family of funds that encompass hedge funds, a long-term capital appreciation fund and private equity funds. Their investor base consists of institutions, pension funds, endowments, funds of funds, family offices and high net worth individuals.

Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds.

Visium Asset Management LP is an independent hedge fund management firm founded by Jacob Gottlieb in 2005. Headquartered in New York City, the firm provides discretionary investment advisory services and sub-advisory services for various long/short equity, credit, event-driven and multi-strategy private investment funds, registered investment companies, an undertaking for collective investment in transferable securities organized under European Union Directors, and separately managed accounts.

Altium Capital Management LP (Altium Capital) is a privately-owned alternative investment manager headquartered in New York City. The firm was founded by Jacob Gottlieb in 2018. Altium Capital manages a fund that focuses on healthcare investments, especially innovative companies with an aim of making significant advances in medical treatments.

Medicus Sciences Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses for its initial business. The company was founded on November 26, 2020 and is headquartered in New York, NY.